Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
Alcon Research
120 participants
Oct 14, 2025
INTERVENTIONAL
Conditions
Summary
The purpose of this study is to collect safety and performance data on two approved intraocular lenses (IOLs). This study will be conducted in participants who require cataract surgery in both eyes. The IOLs are designed to provide vision at far, arm's length, and near.
Eligibility
Inclusion Criteria3
- Subjects with cataracts in both eyes, planned for removal by routine surgery (phacoemulsification);
- Subject must be able to understand and sign an approved informed consent form;
- Subject is willing to complete all the required study visits for the duration of the study;
Exclusion Criteria3
- Ocular conditions as specified in the protocol;
- Subjects who desire monovision correction;
- Previous intraocular or corneal surgery;
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Intraocular lens (IOL) placed into the lens capsule of the eye during cataract surgery. IOLs are implantable medical devices intended for long-term use over the lifetime of the pseudophakic subject.
Cataract surgery technique that uses ultrasound to break up and remove the clouded lens, allowing for IOL implantation.
Locations(5)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07161635